Shares of Gilead Sciences, Inc. (NASDAQ:GILD) ended Friday session in red amid volatile trading. The shares closed down -0.53 points or -0.68% at $76.89 with 7.96 million shares getting traded. Post opening the session at $77.62, the shares hit an intraday low of $76.67 and an intraday high of $77.76 and the price vacillated in this range throughout the day. The company has a market cap of $100.23 billion and the numbers of outstanding shares have been calculated to be 1.32 billion shares.
Gilead Sciences, Inc. (GILD) on August 23, 2016 announced that Kelly A. Kramer has been appointed to the company’s Board of Directors and Audit Committee.
Ms. Kramer is currently Executive Vice President and Chief Financial Officer of Cisco Systems, Inc., which designs and sells products, services and solutions to securely connect everyone and everything. She previously served for 20 years in senior finance positions at General Electric, including as Chief Financial Officer of GE Healthcare’s Healthcare Systems Business. She is a member of the board of the Silicon Valley Chapter of City Year, a non-profit organization that provides educational support for at-risk students in poor communities.
“We are very pleased to welcome Kelly Kramer to the Board of Directors of Gilead Sciences,” said John Martin, PhD, Executive Chairman of Gilead’s Board of Directors. “Kelly’s deep financial expertise in the technology and healthcare industries, including mergers and acquisitions, will be valuable as Gilead continues to grow across multiple therapeutic areas and around the world. I look forward to the contributions and insights that she will bring to the Board.”
Shares of Boston Scientific Corporation (NYSE:BSX) ended Friday session in red amid volatile trading. The shares closed down -0.07 points or -0.29% at $24.26 with 5.51 million shares getting traded. Post opening the session at $24.40, the shares hit an intraday low of $24.12 and an intraday high of $24.43 and the price vacillated in this range throughout the day. The company has a market cap of $33.62 billion and the numbers of outstanding shares have been calculated to be 1.36 billion shares.
Boston Scientific Corporation (BSX) announced that it will participate in the Morgan Stanley Global Healthcare Conference on September 13, in New York City.
Mike Mahoney, chief executive officer, and Dan Brennan, executive vice president and chief financial officer, will participate in a 30-minute question-and-answer-session with the host analyst beginning at approximately 8:00 a.m. EDT.
A live webcast of the question-and-answer-session will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors. We encourage interested parties to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
A replay of the webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.